Alan D Snow
About
Alan D Snow is from Greater Seattle Area. Alan is currently President & CEO at Cognitive Clarity Inc.
If you’re looking for Alan D Snow's email address, you can find it on finalscout.com. Finalscout is a professional database with more than 500 million business professionals and 200 million company profiles.
Alan D Snow's current jobs
Discovered and developed PTI-00703 cat's claw (Uncaria tomentosa) + oolong tea extract for the exclusive and patented ingredients in our Percepta products. Percepta, Percepta Sport and Percepta Professional hit the market in 2018-2019 and are the most scientifically researched and exclusive (patented) memory-support dietary supplements in the world today. Composition of matter patents for Percepta issued in 2019 and for Percepta Professional in 2022, giving us exclusivity until at least 2039. Discovered that PTI-00703 cat's claw gets into the brain (hippocampus, cortex) in 2 minutes after being in the blood and markedly reduces brain plaques, tangles and inflammation - the real reason we lose memory as we age. Two major papers published in Nature -Scientific Reports (top 10 medical journal) in 2019 and 2021. The 2019 paper demonstrates how the polyphenols in cat's claw disrupt and reduce the both brain plaques (beta-amyloid protein) and tangles (tau protein) in the brain. When the cat's claw polyphenols interact with brain plaques and tangles - they fall apart and are near instantly dissolved and then cleared out of the brain by microglia (the pac-man scavengers of the brain). The 108-page 2019 paper represents over 10 years of scientific studies at 8 different institutions and was awarded the Top 100 Most-Downloaded Research Articles from a Nature Journal. The 2021 paper compared the effects of Percepta versus the 20 Top-Selling memory support dietary supplements including Prevagen (Quincy Biosciences), Neuriva (Schiff Vitamins), Alpha Brain (Onnit Labs), Focus Factor (Costco stores), Procera ACH, Cebria (GNC) and many others. Percepta outperformed all of them by >50% in reducing brain plaques (bet-amyloid fibrils) and tau tangles as assessed by in vitro screening on a comparative basis. If interested, please request a copy of these papers that demonstrate the effectiveness of Percepta (and its ingredients) at; dralansnow@cognitiveclarityinc.com